{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:09:27Z","timestamp":1789002567083,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10302204"],"award-info":[{"award-number":["2018ZX10302204"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX10203201003"],"award-info":[{"award-number":["2017ZX10203201003"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901940"],"award-info":[{"award-number":["81901940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070612"],"award-info":[{"award-number":["82070612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010306"],"award-info":[{"award-number":["2021A1515010306"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012241","name":"Guangzhou Research Collaborative Innovation Projects","doi-asserted-by":"publisher","award":["1561000157"],"award-info":[{"award-number":["1561000157"]}],"id":[{"id":"10.13039\/501100012241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12072-022-10335-6","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T10:10:44Z","timestamp":1653559844000},"page":"775-788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Safety and efficacy of Thymosin \u03b11 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial"],"prefix":"10.1007","volume":"16","author":[{"given":"Jun-feng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-ying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-juan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-zhen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-na","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-bao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-liang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4069-6287","authenticated-orcid":false,"given":"Bing-liang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"10335_CR1","first-page":"607","volume":"17","author":"XY Liu","year":"2009","unstructured":"Liu XY, Hu JH, Wang HF. Analysis of prognostic factors for patients with acute-on-chronic liver failure. Chin J Hepatol. 2009;17:607\u2013610","journal-title":"Chin J Hepatol"},{"key":"10335_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.dld.2011.08.029","volume":"44","author":"H Garg","year":"2012","unstructured":"Garg H, Kumar A, Garg V, Sharma P, Sharma BC, Sarin SK. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Digest Liver Dis. 2012;44:166\u2013171","journal-title":"Digest Liver Dis"},{"key":"10335_CR3","first-page":"772","volume":"16","author":"XY Liu","year":"2008","unstructured":"Liu XY, Hu JH, Wang HF, Chen JM. Etiological analysis of 1977 patients with acute liver failure, subacute liver failure and acute-on-chronic liver failure. Chin J Hepatol. 2008;16:772\u2013775","journal-title":"Chin J Hepatol"},{"key":"10335_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12072-009-9148-8","volume":"3","author":"AC Chan","year":"2009","unstructured":"Chan AC, Fan ST, Lo CM, Liu CL, Chan SC, Nq KK, et al. Liver transplantation for acute-on-chronic liver failure. Hepatol Int. 2009;3:571\u2013581","journal-title":"Hepatol Int"},{"key":"10335_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12072-012-9415-y","volume":"7","author":"BL Lin","year":"2013","unstructured":"Lin BL, Pan CQ, Xie DY, Xie JQ, Xie SB, Zhang XH, et al. Entecavir improves the outcome of acute-on- chronic liver failure due to the acute exacerbation of chronic hepatitis B. Hepatol Int. 2013;7:460\u2013467","journal-title":"Hepatol Int"},{"key":"10335_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbrc.2010.09.096","volume":"402","author":"F Shi","year":"2010","unstructured":"Shi F, Zhang JY, Zeng Z, Tien P, Wang FS. Skewed ratios between CD3+ T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure. Biochem Biophys Res Commun. 2010;402:30\u201336","journal-title":"Biochem Biophys Res Commun"},{"key":"10335_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jgh.12082","volume":"28","author":"GL Zhang","year":"2013","unstructured":"Zhang GL, Xie DY, Lin BL, Xie C, Ye YN, Peng L, et al. Imbalance of interleukin-17-producing CD4 T cells\/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroen Hepatol. 2013;28:513\u2013521","journal-title":"J Gastroen Hepatol"},{"key":"10335_CR8","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","volume":"67","author":"J Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez J, Acevedo J, Weist R, Gustot T, Amoros A, Deulofeu C, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2018;67:1870\u20131880","journal-title":"Gut"},{"key":"10335_CR9","first-page":"1","volume":"50","author":"G Rout","year":"2018","unstructured":"Rout G, Jadaun SS, Ranjan G, Kedia S, Gunjan D, Nayak B, et al. Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patients. Digest Liver Dis. 2018;50:1\u20137","journal-title":"Digest Liver Dis"},{"key":"10335_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1530-0277.2006.00074.x","volume":"30","author":"G Linderoth","year":"2006","unstructured":"Linderoth G, Jepsen P, Schonheyder HC, Johnsen SP, Sorensen ST. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: a population-based cohort study. Alcohol Clin Exp Res. 2006;30:636\u2013641","journal-title":"Alcohol Clin Exp Res"},{"key":"10335_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/liv.13568","volume":"38","author":"MM M\u00fccke","year":"2018","unstructured":"M\u00fccke MM, Rumyantseva T, M\u00fccke VT, Schwarzkopf K, Joshi S, Kempf VAJ, et al. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality. Liver Int. 2018;38:645\u2013653","journal-title":"Liver Int"},{"key":"10335_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Mahtab MAI, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353\u2013390","journal-title":"Hepatol Int"},{"key":"10335_CR13","first-page":"638","volume":"17","author":"YN Ye","year":"2009","unstructured":"Ye YN, Gao ZL. Three shock hypotheses that may induce liver failure. Chin J Hepatol. 2009;17:638\u2013640","journal-title":"Chin J Hepatol"},{"key":"10335_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","volume":"42","author":"HE Wasmuth","year":"2005","unstructured":"Wasmuth HE, Kunz D, Yagmur E, Timmer-Strangh\u00f6ner A, Vidacek D, Siewert E, et al. Patients with acute on chronic liver failure display \u2018sepsis-like\u2019 immune paralysis. J Hepatol. 2005;42:195\u2013201","journal-title":"J Hepatol"},{"key":"10335_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-2249.2006.03259.x","volume":"147","author":"T Xing","year":"2007","unstructured":"Xing T, Li L, Cao H, Huang J. Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin Exp Immunol. 2007;147:184\u2013188","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"10335_CR16","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1517\/14712598.2015.1007948","volume":"15","author":"X Wu","year":"2015","unstructured":"Wu X, Jia J, You H. Thymosin alpha1 treatment in chronic hepatitis B. Expert Opin Biol Ther. 2015;15(Suppl 1):S129\u2013S132","journal-title":"Expert Opin Biol Ther"},{"issue":"Suppl 1","key":"10335_CR17","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1517\/14712598.2015.1033393","volume":"15","author":"R Camerini","year":"2015","unstructured":"Camerini R, Garaci E. Historical review of thymosin \u03b1 1 in infectious diseases. Expert Opin Biol Ther. 2015;15(Suppl 1):S117\u2013S127","journal-title":"Expert Opin Biol Ther"},{"issue":"Suppl 1","key":"10335_CR18","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1517\/14712598.2015.1017466","volume":"15","author":"E Garaci","year":"2015","unstructured":"Garaci E, Pica F, Matteucci C, Gaziano R, D\u2019Agostini C, Miele MT, et al. Historical review on thymosin \u03b11 in oncology: preclinical and clinical experiences. Expert Opin Biol Ther. 2015;15(Suppl 1):S31\u2013S39","journal-title":"Expert Opin Biol Ther"},{"key":"10335_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.imlet.2007.04.007","volume":"110","author":"Q Yao","year":"2007","unstructured":"Yao Q, Doan LX, Zhang R, Bharadwaj U, Li M, Chen C. Thymosin-\u03b11 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes. Immunol Lett. 2007;110:110\u2013120","journal-title":"Immunol Lett"},{"key":"10335_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1086\/590500","volume":"198","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Chen H, Li YM, Zeng SS, Chen YG, Li LJ, et al. Thymosin \u03b11- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria. J Infect Dis. 2008;198:723\u2013730","journal-title":"J Infect Dis"},{"key":"10335_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12879-016-1823-5","volume":"16","author":"F Liu","year":"2016","unstructured":"Liu F, Wang HM, Wang T, Zhang YM, Zhu X. The efficacy of thymosin \u03b11 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials. BMC Infect Dis. 2016;16:488","journal-title":"BMC Infect Dis"},{"key":"10335_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijid.2014.12.032","volume":"33","author":"C Li","year":"2015","unstructured":"Li C, Bo L, Liu Q, Jin F. Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis. Int J Infec Dis. 2015;33:90\u201396","journal-title":"Int J Infec Dis"},{"key":"10335_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","volume":"8","author":"SK Sarin","year":"2014","unstructured":"Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan ACY, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) 2014. Hepatol Int. 2014;8:453\u2013471","journal-title":"Hepatol Int"},{"key":"10335_CR24","unstructured":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, CMA. Diagnostic and Treatment Guidelines for Liver Failure in China (2012). Chin J Clin Infect Pis 2012;5:321\u20137."},{"key":"10335_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2010.02.023","volume":"53","author":"S M\u00f8ller","year":"2010","unstructured":"M\u00f8ller S. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397\u2013417","journal-title":"J Hepatol"},{"key":"10335_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3:269\u2013282","journal-title":"Hepatol Int"},{"issue":"sup1","key":"10335_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/14712598.2018.1451511","volume":"18","author":"X Wu","year":"2018","unstructured":"Wu X, Shi Y, Zhou J, Sun Y, Piao H, Jiang W, et al. Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study. Expert Opin Biol Ther. 2018;18(sup1):61\u201369","journal-title":"Expert Opin Biol Ther"},{"key":"10335_CR28","first-page":"3231","volume":"15","author":"X Yang","year":"2018","unstructured":"Yang X, Chen Y, Zhang J, Tang T, Kong Y, Ye F, et al. Thymosin \u03b11 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure. Exp Ther Med. 2018;15:3231\u20133238","journal-title":"Exp Ther Med"},{"key":"10335_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cmi.2014.12.026","volume":"21","author":"SH Hoeboer","year":"2015","unstructured":"Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21:474\u2013481","journal-title":"Clin Microbiol Infect"},{"key":"10335_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12291-013-0326-z","volume":"29","author":"D Anand","year":"2014","unstructured":"Anand D, Das S, Ray S, Bhargava S, Srivastava LM. Interrelationship between procalcitonin and organ failure in sepsis. Indian J Clin Biochem. 2014;29:93\u201396","journal-title":"Indian J Clin Biochem"},{"key":"10335_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/701480","volume":"2015","author":"C Leli","year":"2015","unstructured":"Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci A. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015;2015:1\u20138","journal-title":"Dis Markers"},{"key":"10335_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1735-1995.183996","volume":"21","author":"S Li","year":"2016","unstructured":"Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci. 2016;21:39","journal-title":"J Res Med Sci"},{"key":"10335_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1365-2893.2006.00761.x","volume":"13","author":"RN Chien","year":"2006","unstructured":"Chien RN, Lin CY, Yeh CT, Liaw YF. Hepatitis B virus genotype B is associated with better response to thymosin \u03b11 therapy than genotype C. J Viral Hepatitis. 2006;13:845\u2013850","journal-title":"J Viral Hepatitis"},{"key":"10335_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2893.2005.00633.x","volume":"12","author":"S Iino","year":"2005","unstructured":"Iino S, Toyota J, Kumada H, Kiyosawa K, Kakumu S, Sata M, et al. The efficacy and safety of thymosinalpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. J Viral Hepatitis. 2005;12:300\u2013306","journal-title":"J Viral Hepatitis"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10335-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T12:32:38Z","timestamp":1659529958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10335-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10335"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10335-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"6 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this study, Sciclone pharmaceuticals, as the Marketing Authorization Holder of T\u03b1-1 in China, reported SAEs to the drug and regulatory and health authorities after being informed by investigators. Sciclone did not play any role in the design, conduct or funding of this study. The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study conformed strictly to the Ethical Guidelines of the 1975 Declaration of Helsinki. The study protocol was approved by the Ethics Committee on Clinical Trials of the Third Affiliated Hospital of Sun Yat-sen University in 2016. This study is registered at ClinicalTrials.gov (NCT 03082885). Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent for publication was obtained from all co-authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}